FDA label f18f1137-4bdc-6155-e053-2995a90a688f

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: dde4ccf4-152d-441a-bad1-53975bab5987
SPL ID: f18f1137-4bdc-6155-e053-2995a90a688f
Version: 4
Effective date: 2023-01-05
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:58:14

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		f18f1137-4bdc-6155-e053-2995a90a688f	id
spl set id		dde4ccf4-152d-441a-bad1-53975bab5987	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: Do not take this product if you have any of the following: • heart disease • diabetes • high blood pressure • thyroid disease • or di culty in urination due to the enlargement of the prostate gland When using this product: DO NOT EXCEED RECOMMENDED DOSAGE. Stop use and ask a doctor if: • nervousness, dizziness or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by high fever • redness or swelling occur Drug Interaction Precaution: Do not use this product if you are now taking prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains an MAOI consult a health professional before taking this product.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.